⌘K

Home/Filings/4/0001104659-21-076998

4//SEC Filing

Kelly Leanne M. 4

Accession 0001104659-21-076998

CIK 0001824293other

View on SEC.gov Company Profile

Filed

Jun 3, 8:00 PM ET

Accepted

Jun 4, 4:06 PM ET

Size

7.5 KB

Accession

0001104659-21-076998

Insider Transaction Report

Form 4

Period: 2021-06-02

Vallon Pharmaceuticals, Inc.VLON

Chief Financial Officer

Transactions

Purchase
Common Stock
2021-06-02$4.00/sh+3,657$14,628→ 3,657 total
Purchase
Common Stock
2021-06-03$4.05/sh+1,085$4,394→ 4,742 total
Purchase
Common Stock
2021-06-04$4.08/sh+1,508$6,153→ 6,250 total

Documents

1 file

4
tm2118823d1_4.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

Vallon Pharmaceuticals, Inc.

CIK 0001824293

Entity typeother

Related Parties

1

filerCIK 0001398278

Filing Metadata

Form type: 4
Filed: Jun 3, 8:00 PM ET
Accepted: Jun 4, 4:06 PM ET
Size: 7.5 KB

View on SEC.gov